CLINICAL_TRIALS
trial_result
· 2025-03-26
Clinical Trial Update: Rituximab (RTX) Therapy in Patients With Active TAO [Phase 4]
Summary
Phase 4 trial of Rituximab for active thyroid-associated ophthalmopathy has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Göteborg University | Conditions: Ophthalmopathy, Thyroid-Associated | Phase 4 | Status: COMPLETED | Results posted: 2025-03-26